Please login to the form below

Not currently logged in

e-Therapeutics appoints new CEO

Dr Raymond Barlow joins firm from Amgen

UK-based drug discovery and development firm e-Therapeutics appoints Dr Raymond Barlow as its new CEO.

Prior to e-Therapeutics, Barlow worked for a number of global pharma companies, including AstraZeneca as its director of corporate development and most recently at Amgen working on deals with Boehringer Ingelheim, GlaxoSmithKline and Geneta.

He said: “e-therapeutics is at the forefront of a new wave of science and has created a unique, computational-based drug discovery platform. This platform uses a range of truly cutting-edge technologies, including artificial intelligence.

“I am looking forward to engaging with our key stakeholders as well as subsequently positioning and promoting the company to an industry which needs the assets and solutions we can provide.”

10th April 2017

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...
The rise of real-world evidence
Demonstrating efficacy and value requires more than clinical trial data...
Digital health
The untapped potential to transform healthcare...